NASDAQ:TPST

Tempest Therapeutics (TPST) News Today

$1.53

-0.09 (-5.56%)

(As of 05/31/2023 ET)

Compare

Today's Range: $1.53
▼
$1.69
50-Day Range: $1.36
▼
$3.76
52-Week Range: $1.06
▼
$4.21

Volume: 59,901 shs
Average Volume: 161,031 shs
Market Capitalization: $17.73 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $10.00

Get Tempest Therapeutics News Delivered to You Automatically

TPST Media Mentions By Week

TPST Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

TPST
News Sentiment
▼
0.15

0.78
▲
Average
Medical
News Sentiment

TPST News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

TPST Articles
This Week
▼
5

1
▲
TPST Articles
Average Week

Source

Source	Headline
	Tempest to Present at the Jefferies Global Healthcare Conference finance.yahoo.com - May 31 at 8:26 PM
	Analyst Ratings for Tempest Therapeutics markets.businessinsider.com - May 30 at 7:42 PM
	Tempest to Present Phase 1 Monotherapy and Combination Data at ASCO for TPST-1495 in Patients with Advanced Cancers finance.yahoo.com - May 25 at 7:44 PM
	Tempest to Present Phase 1 Monotherapy and Combination Data at ASCO for TPST-1495 in Patients with Advanced Cancers finance.yahoo.com - May 25 at 7:44 PM
	Tempest Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) finance.yahoo.com - May 19 at 5:59 PM
	Tempest Therapeutics, Inc. Forecasted to Earn Q2 2023 Earnings of ($0.64) Per Share (NASDAQ:TPST) americanbankingnews.com - May 17 at 1:36 AM
	Tempest Therapeutics, Inc. to Post Q2 2023 Earnings of ($0.52) Per Share, William Blair Forecasts (NASDAQ:TPST) americanbankingnews.com - May 16 at 1:28 AM
	HC Wainwright & Co. Reiterates Tempest Therapeutics (TPST) Buy Recommendation msn.com - May 12 at 10:20 AM
	Tempest Therapeutics: Tempest Reports First Quarter 2023 Financial Results and Provides Business Update finanznachrichten.de - May 11 at 2:58 PM
	Analysts Have Conflicting Sentiments on These Healthcare Companies: Tempest Therapeutics (TPST), MannKind (MNKD) and Alkermes (ALKS) markets.businessinsider.com - May 11 at 9:57 AM
	Tempest Reports First Quarter 2023 Financial Results and Provides Business Update finance.yahoo.com - May 10 at 6:48 PM
	Tempest Reports First Quarter 2023 Financial Results and Provides Business Update finance.yahoo.com - May 10 at 6:48 PM
	Tempest Therapeutics, Inc. (TPST) Upgraded to Buy: What Does It Mean for the Stock? msn.com - May 1 at 2:38 PM
	Tempest Therapeutics (NASDAQ:TPST) Price Target Raised to $14.00 americanbankingnews.com - May 1 at 1:52 AM
	8-K: Tempest Therapeutics, Inc. marketwatch.com - April 29 at 10:37 AM
	Ladenburg Thalmann Maintains Tempest Therapeutics (TPST) Buy Recommendation msn.com - April 29 at 10:37 AM
	Short Interest in Tempest Therapeutics, Inc. (NASDAQ:TPST) Declines By 29.9% americanbankingnews.com - April 29 at 8:08 AM
	Tempest Announces Positive Results From Phase 1b/2 Trial Of TPST-1120 In Hepatocellular Cancer markets.businessinsider.com - April 28 at 1:52 PM
	Tempest Soars after Positive Clinical Data for TPST-1120 msn.com - April 28 at 1:52 PM
	Tempest surges ~40% as TPST-1120 shows promise in liver cancer trial msn.com - April 28 at 1:52 PM
	Tempest Announces Positive Early Results from Global Randomized Phase 1b/2 Combination Study of TPST-1120 in First-Line Hepatocellular Carcinoma finance.yahoo.com - April 28 at 8:51 AM
	Tempest to Report Early Results from Global Randomized Phase 1b/2 Combination Study of TPST-1120 in First-Line Hepatocellular Carcinoma finance.yahoo.com - April 27 at 6:51 PM
	Tempest Announces TPST-1495 Poster Presentation at the 2023 ASCO Annual Meeting benzinga.com - April 26 at 8:02 PM
	Tempest Announces TPST-1495 Poster Presentation at the 2023 ASCO Annual Meeting finance.yahoo.com - April 26 at 8:02 PM
	Tempest Announces New Translational and Preclinical Data Presented at the 2023 AACR Annual Meeting finance.yahoo.com - April 17 at 10:07 AM
	Tempest Therapeutics, Inc. (NASDAQ:TPST) Short Interest Update americanbankingnews.com - March 31 at 7:26 AM
	Tempest Therapeutics Stock (NASDAQ:TPST), Dividends benzinga.com - March 30 at 2:09 PM
	Tempest Therapeutics, Inc. Forecasted to Earn Q2 2023 Earnings of ($0.71) Per Share (NASDAQ:TPST) americanbankingnews.com - March 28 at 1:38 AM
	Tempest Therapeutics (NASDAQ:TPST) Given New $6.00 Price Target at Piper Sandler americanbankingnews.com - March 26 at 4:24 AM
	Shakespeare’s The Tempest plot summary bbc.co.uk - March 24 at 9:53 AM
	Equities Analysts Offer Predictions for Tempest Therapeutics, Inc.'s Q1 2023 Earnings (NASDAQ:TPST) americanbankingnews.com - March 24 at 6:18 AM
	HC Wainwright Reiterates Buy Rating for Tempest Therapeutics (NASDAQ:TPST) americanbankingnews.com - March 24 at 5:32 AM
	Tempest Therapeutics: Tempest Reports Year End 2022 Financial Results and Provides Business Update finanznachrichten.de - March 23 at 7:28 AM
	Tempest Reports Year End 2022 Financial Results and Provides Business Update finance.yahoo.com - March 22 at 10:36 PM
	Tempest Reports Year End 2022 Financial Results and Provides Business Update finance.yahoo.com - March 22 at 5:35 PM
	Tempest to Present Biomarker Data for TPST-1120 at the Society for Immunotherapy of Cancer (SITC) 2023 Spring Scientific Meeting finance.yahoo.com - March 15 at 6:44 PM
	Tempest to Present Biomarker Data for TPST-1120 at the Society for Immunotherapy of Cancer (SITC) 2023 Spring Scientific Meeting finance.yahoo.com - March 15 at 6:44 PM
	Tempest to Present New Translational and Preclinical Data at the 2023 AACR Annual Meeting finance.yahoo.com - March 14 at 9:36 PM
	KS2 Music: The Tempest bbc.co.uk - February 18 at 6:07 PM
	Bears are Losing Control Over Tempest Therapeutics, Inc. (TPST), Here's Why It's a 'Buy' Now finance.yahoo.com - December 5 at 6:34 PM
	Tempest to Present at the Piper Sandler 34th Annual Healthcare Conference finance.yahoo.com - November 22 at 6:24 PM
	Tempest Presents Data Showing TPST-1120-Induced Pharmacodynamic Changes Consistent with Clinical Benefit Observed in Patients with Cancer finance.yahoo.com - November 10 at 3:47 PM
	Tempest Reports Third Quarter 2022 Financial Results and Provides Business Update finance.yahoo.com - November 8 at 8:56 AM
	Tempest Announces Data Presentations, including a Late-Breaking Presentation on TPST-1120, at the SITC Annual Meeting finance.yahoo.com - November 2 at 1:11 PM
	6KMPH, DDI : Benzinga's Top Ratings Upgrades, Downgrades For... msn.com - September 15 at 11:34 AM
	Tempest to Present at the H.C. Wainwright 24th Annual Global Investment Conference finance.yahoo.com - September 7 at 10:10 AM
	Tempest to Present at the H.C. Wainwright 24th Annual Global Investment Conference finance.yahoo.com - September 7 at 10:10 AM
	Tempest Therapeutics GAAP EPS of -$0.79 seekingalpha.com - August 17 at 8:21 PM
	Tempest Therapeutics, Inc. Tops Q2 EPS by 13c investing.com - August 17 at 12:19 AM
	Tempest Reports Second Quarter 2022 Financial Results and Provides Business Update finance.yahoo.com - August 15 at 8:22 AM

Get Tempest Therapeutics News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (NASDAQ:TPST) was last updated on 6/1/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Tempest Therapeutics (TPST) News Today

TPST Media Mentions By Week

TPST Media Sentiment

TPST News Coverage

Related Companies and Tools

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info